Similar approaches were applied to Dipeptidyl-peptidase IV (DPP-IV), which can be considered another appealing therapeutic target as DPP-IV inhibitors can be effective in treating type 2 diabetes. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.